Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYTH - Cyclo Therapeutics names seasoned biotechnology executive as acting CMO

CYTH - Cyclo Therapeutics names seasoned biotechnology executive as acting CMO

Cyclo Therapeutics Inc.
Cyclo Therapeutics (CYTH) traded 7.8% higher premarket on appointing Gerald F. Cox, MD, PhD as acting chief medical officer; Dr. Cox has 20+ years of experience in drug development for rare diseases."As we continue to advance our Trappsol Cyclo clinical development programs, we are incredibly pleased to have secured the interest of Dr. Cox. The expertise and guidance he can provide as we execute on our clinical and regulatory strategies to treat systemic and neurologic manifestations of Niemann-Pick Type C and Alzheimer's Disease will be invaluable," CEO N. Scott Fine commented.

For further details see:

Cyclo Therapeutics names seasoned biotechnology executive as acting CMO
Stock Information
Company Name: Cyclo Therapeutics Inc.
Stock Symbol: CYTH
Market: NASDAQ
Website: cyclodex.com
Menu
CYTH CYTH Quote CYTH Short CYTH News CYTH Articles CYTH Message Board
Get CYTH Alerts

News, Short Squeeze, Breakout and More Instantly...